Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

20S Proteasome α4 Activators

The Proteasome α4 (also known as PSMA4 or Alpha type-4 proteasome subunit) is a part of the 20S proteasome core complex. 20S Proteasome α4 activators refer to a diverse set of chemical compounds that modulate the activity of the α4 subunit within the 20S proteasome complex. The 20S proteasome is a core component of the proteasome complex, which plays a critical role in the ubiquitin-proteasome system responsible for the degradation of most intracellular proteins. This system is essential for maintaining cellular homeostasis by regulating protein turnover and removing damaged or misfolded proteins. The 20S proteasome is a cylindrical structure composed of four stacked rings, each containing seven distinct subunits. The α4 subunit is one of the seven alpha subunits that form the outer rings of the 20S proteasome, and these alpha rings serve primarily as regulatory components controlling access to the inner catalytic chamber formed by the beta subunits. While the alpha subunits themselves are not directly involved in proteolysis, their proper functioning is essential for the regulation of proteasome activity.

Activators of the 20S Proteasome α4 subunit work by a variety of mechanisms. Direct activators bind to the α4 subunit and induce a conformational change that propagates through the structure, resulting in an alteration of the proteasome's activity. This involves the opening of the gate that controls substrate entry into the catalytic core, thereby increasing the rate of protein degradation. Indirect activators enhance the expression of the PSMA7 gene, which encodes the α4 subunit, leading to an increased synthesis of this subunit and potentially an upregulation of proteasome assembly and activity. Alternatively, indirect activators act by stabilizing the α4 subunit against degradation or by modulating the interaction of the α4 subunit with other regulatory proteins that influence proteasome activity

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

Carfilzomib is a selective proteasome inhibitor that primarily targets the β5 subunit. It could indirectly affect the α4 subunit by altering proteasome function.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG-132 is a proteasome inhibitor that can prevent the degradation of ubiquitin-tagged proteins, thus indirectly affecting the function of the α4 subunit.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Epoxomicin is a potent, selective, and irreversible proteasome inhibitor. It could indirectly influence the α4 subunit by preventing proteasome function.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Lactacystin is a proteasome inhibitor that can prevent the degradation of ubiquitin-tagged proteins, indirectly affecting the function of the α4 subunit.

ONX 0914

960374-59-8sc-477437
5 mg
$245.00
(0)

ONX-0914 is a selective inhibitor of the immunoproteasome subunit LMP7. It could indirectly affect the α4 subunit by altering proteasome function.